Iowa Admin. Code r. 641-156.4

Current through Register Vol. 47, No. 11, December 11, 2024

Rule 641-156.4 - Packaging and labeling

(1)Contents. Each consumable hemp product intended for individual retail sale is labeled such that a reasonable consumer would plainly identify the product as a consumable hemp product and contains the following information:

a. Lot number for the batch;

b. Expiration date;

c. Brand name;

d. Product name;

e. List of ingredients;

f. Name, telephone number, and email address of the product manufacturer. If the registered manufacturer uses a contracted third-party or white-label manufacturer, the name of that entity must also be included on the container or label and is not proprietary or confidential under Iowa Code section 22.7;

g. If specific cannabinoids are contained within or marketed for the product, the number of milligrams of each cannabinoid per serving and serving size;

h. A certificate of analysis that the batch contained a total THC concentration that did not exceed 0.3 percent on a dry weight basis as calculated pursuant to an official test as provided in Iowa Code section 204.8;

i. A declaration of the net quantity of contents indicating the number of servings and total THC per serving and per container in compliance with Iowa Code section 204.2; and

j. A warning label containing the following or substantially similar language, in addition to any other warning language necessitated by the specific product. This warning label may be divided into multiple sections on a label, provided that all the information is included in a prominent and conspicuous manner as compared to other words, statements, or designs on the container label:

(1) A statement that the product has not been evaluated or approved by the United States Food and Drug Administration (unless such approval has been secured);

(2) The potential for the product to cause the consumer to fail a drug test for THC;

(3) A statement that products containing THC may cause impairment and impact a consumer's ability to operate a vehicle;

(4) A statement that the product is not recommended for use by pregnant or breastfeeding women;

(5) A statement that product use may result in health risks and medication interactions; and

(6) A statement in capital letters to KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.

The labeling must not contain any claim that the product may be used or is effective for the prevention, treatment, or cure of a disease or that it may be used to alter the structure or function of human or animal bodies unless the claim has been approved by the federal Food and Drug Administration.

(2)Form. The labeling mandated in paragraphs 156.4(1)"f" and "h" may be in the form of:

a. A uniform resource locator (URL) for the manufacturer's Internet website that provides or links to the information mandated by this rule; or

b. A QR code or other bar code that may be scanned and that leads to the information required on the label.

Iowa Admin. Code r. 641-156.4

Adopted by IAB August 7, 2024/Volume XLVII, Number 4, effective 7/17/2024